H2S inhibits the activation of hepatic stellate cells and downregulates the expression of urotensin II

The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo

(2011) Zheng Wei Lee et al.   PLoS One

Hydrogen Sulfide Attenuates Carbon Tetrachloride-Induced Hepatotoxicity, Liver Cirrhosis and Portal Hypertension in Rats

(2011) Gang Tan et al.   PLoS One

Genetic and Pharmacologic Hydrogen Sulfide Therapy Attenuates Ischemia-Induced Heart Failure in Mice

(2010) John W. Calvert et al.   CIRCULATION

Hydrogen sulfide protects neurons against hypoxic injury via stimulation of ATP-sensitive potassium channel/protein kinase C/extracellular signal-regulated kinase/heat shock protein90 pathway

(2010) A.S. Tay et al.   NEUROSCIENCE

Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3β signaling pathway

(2010) D. Gruson et al.   PEPTIDES

Hydrogen Sulfide, a Gaseous Transmitter, Stimulates Proliferation of Interstitial Cells of Cajal via Phosphorylation of AKT Protein Kinase

(2010) Ying Huang et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats

(2009) William Kemp et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats

(2009) Kai Kang et al.   LIVER TRANSPLANTATION

Hydrogen sulfide suppresses migration, proliferation and myofibroblast transdifferentiation of human lung fibroblasts

(2009) Li-Ping Fang et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Characterization of a Novel, Water-Soluble Hydrogen Sulfide–Releasing Molecule (GYY4137)

(2008) Ling Li et al.   CIRCULATION

Mechanisms of Hepatic Fibrogenesis

(2008) Scott L. Friedman   GASTROENTEROLOGY

Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis

(2007) Angelo Gatta et al.   MOLECULAR ASPECTS OF MEDICINE